A Phase 1b Trial of the Combination of Capecitabine and Erlotinib in Advanced Lung Cancer

被引：0
|
作者：
Kumar, Rajiv [1 ]
Lo, Karl [1 ]
Minchom, Anna R. [1 ]
Sharp, Adam [1 ]
Davidson, Michael [1 ]
Gunapala, Ranga [1 ]
Yap, Timothy [2 ,3 ]
Bhosle, Jaishree [1 ]
Popat, Sanjay [1 ]
O'Brien, Mary E. R. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Dept Lung Med, London, Surrey, England
[2] Inst Canc Res, Dept Lung Med, London, Surrey, England
[3] Royal Marsden NHS Fdn Trust, London, Surrey, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Erlotinib; Capecitabine; Non-small-cell lung cancer; Phase; 1;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-077
引用
收藏
页码：S547 / S548
页数：2
相关论文
共 50 条
  • [41] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
    Khatri, P.
    Kumari, P.
    Beniwal, S.
    Samdariya, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
  • [42] Phase I trial of vorinostat in combination with erlotinib for advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations after erlotinib progression
    Reguart, Noemi
    Isla, Dolores
    Cardenal, Felipe
    Cardona, Andres
    Palmero, Ramon
    Moran, Teresa
    Rolfo, Christian Diego
    Nadal, Ernesto Samuel
    Massuti, Tomeu
    Montanes, Ana
    Queralt, Cristina
    Taron, Miquel
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S708 - S708
  • [43] Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer
    Moon, D. H.
    Mcree, A. J.
    Blackstock, A. W.
    O'Neil, B. H.
    Moore, D. T.
    Calvo, B. F.
    Lee, M. S.
    Murphy, C.
    Caliri, K.
    Tynan, M. T.
    Senderowicz, A. M.
    Tepper, J. E.
    Sanoff, H. K.
    Wang, A. Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S66 - S66
  • [44] Safety and tolerability of veliparib combined with capecitabine plus radiotherapy in patients with locally advanced rectal cancer: a phase 1b study
    Czito, Brian G.
    Deming, Dustin A.
    Jameson, Gayle S.
    Mulcahy, Mary F.
    Vaghefi, Houman
    Dudley, Matthew W.
    Holen, Kyle D.
    DeLuca, Angela
    Mittapalli, Rajendar K.
    Munasinghe, Wijith
    He, Lei
    Zalcberg, John R.
    Ngan, Samuel Y.
    Komarnitsky, Philip
    Michael, Michael
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (06): : 418 - 426
  • [45] Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
    Cardin, Dana B.
    Goff, Laura
    Li, Chung-I
    Shyr, Yu
    Winkler, Charles
    DeVore, Russell
    Schlabach, Larry
    Holloway, Melanie
    McClanahan, Pam
    Meyer, Krista
    Grigorieva, Julia
    Berlin, Jordan
    Chan, Emily
    CANCER MEDICINE, 2014, 3 (03): : 572 - 579
  • [46] Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer.
    Shatsky, Rebecca
    Messer, Karen
    Helsten, Teresa L.
    Schwab, Richard B.
    Pittman, Emily I.
    Chen, Ruifeng
    Weihe, Elizabeth
    Widhopf, George
    Ghia, Emmanuela M.
    Rassenti, Laura Z.
    Alfred, Molinolo A.
    Breitmeyer, James
    Jamieson, Catriona H.
    Kipps, Thomas J.
    Parker, Barbara A.
    CANCER RESEARCH, 2021, 81 (13)
  • [47] Phase II trial of erlotinib in advanced pancreatic cancer (PC)
    Tang, P.
    Gill, S.
    Au, H. J.
    Chen, E. X.
    Hedley, D.
    Leroux, M.
    Wang, L.
    Moore, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase I study of capecitabine and erlotinib with radiotherapy in locally advanced nonoperable pancreatic cancer
    Jiang, Y.
    Kimchi, E.
    Gusani, N. J.
    Mackley, H. B.
    Staveley-O'Carroll, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial
    Solomon, Benjamin J.
    Dagogo-Jack, Ibiayi
    Lee, Se-Hoon
    Boyer, Michael J.
    Ramalingam, Suresh S.
    Carcereny, Enric
    Felip, Enriqueta
    Han, Ji-Youn
    Hida, Toyoaki
    Hughes, Brett G. M.
    Kim, Sang -We
    Nishio, Makoto
    Seto, Takashi
    Okamoto, Tatsuro
    Zhang, Xiaoxi
    Martini, Jean -Francois
    Wang, Erjian
    De Beukelaer, Steven
    Bauer, Todd M.
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (07):
  • [50] Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non–small cell lung cancer patients with asymptomatic brain metastases
    Hiroyasu Kaneda
    Kenji Sawa
    Haruko Daga
    Asuka Okada
    Yuki Nakatani
    Shinji Atagi
    Kyoichi Okishio
    Yoko Tani
    Yoshiya Matsumoto
    Koichi Ogawa
    Kenji Nakahama
    Motohiro Izumi
    Shigeki Mitsuoka
    Tomoya Kawaguchi
    Investigational New Drugs, 2021, 39 : 1598 - 1603
12345